Fluorescent Nanoparticles for Biocompatible Tissue Imaging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional optical labels used in medical imaging are toxic, prone to photobleaching, sensitive to environmental changes, and inefficient, with narrow excitation spectra and broad emission spectra leading to overlapping signals and the need for multiple filters.

Innovation Solution

The use of biocompatible fluorescent nanoparticles with a fluorophore core and silica shell, capable of emitting light in the near-infrared range for deep tissue penetration, and visible range for surface imaging, along with adaptive devices and methods for delivering and viewing these nanoparticles within the body.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional optical labels (fluorescent dyes) are used for tissue imaging, then the imaging function is achieved, but the labels are toxic to living cells and tissues

Engineering Contradiction:
Improveimaging functionVSAvoidtoxicity to living cells
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses composite fluorescent nanoparticles consisting of a fluorophore core encapsulated within a biocompatible silica shell. This composite structure maintains the fluorescent imaging function while the silica shell provides biocompatibility and reduces toxicity to living cells and tissues.

Inventive Principle:
Principle #40Composite materials

2Reliability

If conventional fluorescent dyes are used, then imaging is achieved, but the dyes undergo photobleaching after minutes of exposure resulting in short-lived fluorescence

Engineering Contradiction:
Improveimaging functionVSAvoidfluorescence duration
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The biocompatible silica shell encapsulating the fluorophore core protects the fluorescent material from photobleaching and environmental degradation, enabling stable fluorescence emission over extended monitoring periods rather than just minutes.

Inventive Principle:
Principle #30Flexible shells and thin films

3Reliability

If conventional optical labels are used, then imaging is achieved, but the excitation spectra are narrow while emission spectra are broad causing overlapping signals

Engineering Contradiction:
Improveimaging functionVSAvoidsignal overlap
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The patent utilizes fluorescent nanoparticles with tuned optical parameters, specifically selecting fluorophores with appropriate absorption and emission wavelengths that minimize spectral overlap. The silica shell also modifies the optical properties by reducing environmental sensitivity, thereby maintaining distinct emission spectra for multiplexed imaging.

Inventive Principle:
Principle #35Parameter changes

4Reliability

If conventional fluorescent dyes are used, then imaging is achieved, but the conversion efficiency from excitation light to emission wavelength is low resulting in weak signals

Engineering Contradiction:
Improveimaging functionVSAvoidconversion efficiency
Core Design Contradiction:
ReliabilityVSLoss of energy

Solution Approach 1:

The fluorescent nanoparticle composite structure with optimized fluorophore core and silica shell enhances the quantum yield and conversion efficiency from excitation to emission wavelength, producing stronger fluorescent signals compared to conventional dyes.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables precise, non-toxic, and efficient marking, illumination, and imaging of tissues with reduced photobleaching and environmental sensitivity, allowing for extended monitoring and improved diagnostic capabilities.

Implementation Method 1

fluorescent nanoparticles... capable of emitting light in the near-infrared range for deep tissue penetration, and visible range for surface imaging

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 2

a filter adapted to transmit light in the fluorescent waveband

Methodology Applied
Scientific EffectOptical filtering: Filter (optical)

Implementation Method 3

near infrared light (600-1300 nm) tends to coincide with minima in the spectral absorption curve of tissue, and thus allows the deepest penetration and transmission of light

Methodology Applied
Scientific EffectAbsorption: Absorption (EM radiation)

Data Source

PatentUS8062215B2Fluorescent nanoparticle scope
Publication Date: 2011.11.22 ETHICON ENDO SURGERY INC
  • US8062215B2 patent drawing
  • US8062215B2 patent drawing
  • US8062215B2 patent drawing

AI summary

Various compositions, methods, and devices are provided that use fluorescent nanoparticles to function as markers, indicators, and light sources. In one embodiment, an endoscopic adaptor is provided for viewing fluorescent nanoparticles. The adaptor can be configured to removably mate to a portion of an endoscope, such as an eyepiece, and it can be adapted to contain a filter for filtering light received through the viewing lumen of the eyepiece. In an exemplary embodiment, the filter is configured to transmit fluorescent light while blocking visible light, to thereby enable a structure containing one or more fluorescent nanoparticles to be viewed through the endoscope.